ALTERNATIVE CANCER SOLUTION

 Alternative Medicine Cancer Therapy

Mark A Rosenberg, MD
Dr. Rosenberg has been involved with drug research since 1991. Having studied the mechanisms of cancer treatment failure, the following concept has become blatantly apparent to Dr. Rosenberg. There are many substances that are toxic to cancer cells in vitro (outside of the body, in a culture medium), including chemotherapy and intravenous antioxidant therapy. These therapies, however, are more often then not, ineffective in vivo (inside the body). The primary reason for the ineffectiveness is that tumor blood flow is poor, resulting in a tumor that actually receives very little of the cytotoxic therapy that is being administered. In addition, poor tumor blood flow is associated with higher grade tumors and greater incidence of metastasis.

Dr. Rosenberg has since concentrated his efforts on improving blood flow to the cancer, while administering cytotoxic intravenous antioxidant therapy. In addition to using vasodilating therapy such as carbogen and isosorbide dinitrate, Dr. Rosenberg has just been granted approval status for an IND (investigational new drug) using Angiotensin II. Angiotensin II is frequently used in Japan in conjunction with chemotherapy to improve tumor blood flow.

Dr. Rosenberg recently appeared on Fox News in 2006, for inducing remission on a patient with metastatic lung cancer (to liver and spine) that was refractory to chemotherapy.

Curriculum Vitae for Mark Rosenberg, MD, FACEP

Education

• July 1990 – July 1993 Emergency Medicine Residency
  Brooke Army Medical Center
  Dept. of Emergency Medicine
  San Antonio, TX
• July 1988 – July 1989 Transitional Internship
  Fitzsimons Army Medical Center
  Aurora, CO
• July 1984 – May 1988 Doctor of Medicine
  Georgetown University School of Medicine
  Washington, DC
• July 1982 – June 1983 Master of Science in Physiology
  Georgetown University Graduate School
  Washington, DC
• Sept 1978 – May 1982 Bachelor of Arts in Biology
  University of Pennsylvania
  Philadelphia, PA
  
  

Committees/Advisory Board

• 2003 - 2005; Chairman of Pharmacy and Therapeutics Committee,
  Bethesda Memorial Hospital
• 2003 – 2005; Institutional Review Board, Bethesda Memorial Hospital
• 2003 – Present; Consultant to the National Strength and Conditioning Assoc.
• 2000 – 2005; Emergency Department Committee,
  Bethesda Memorial Hospital
• 1999 – Present; Medical Advisor to Fitness Institute International
• 1990 – Present; American College of Emergency Physicians

Certifications

• 2001; Diplomate of the American Academy of Anti-aging Medicine
• 1996; Fellow of the American College of Emergency Physicians
• 1994; Board-Certified by the American Board of Emergency Medicine
• 1989; Diplomate of the National Board of Medical Examiners
• 1989-1999; ATLS Provider and Instructor, American College of Surgeons
• 1990-1992; PALS Provider, American Academy of Pediatrics
• 1988-Present; ACLS Provider, American Heart Association
• 1998; Certified Hypnotherapist, National Guild of Hypnotists
• 1998; Certified Personal Trainer, National Strength and Conditioning Assoc.

Awards

• 1989; US Army Certificate of Achievement Award, for performance above and
  beyond the call of duty during the tornado disaster in Alabama
• 1989; US Army Commendation Medal
• 1993; Award for Outstanding Senior Resident and Teacher
• 1999; Valedictorian and Distinguished Speaker, Fitness Institute International
• 1999; Cover of the monthly journal, “The Florida Hypnotist”
  
  

Publications

• Epstein A, Zhang D, Schultz J, Rosenberg M, Kupcha P, Stellar E:
  The Failure of Ventricular Sodium to Control Sodium Appetite in the Rat;
  Journal of Physiology and Behavior. 32:683-686, 1984
• Rosenberg, Mark A: Toxndex, Toxicological Emergency Reference Manual;
  Delray Beach, FL, MQ INC, 1991
• Patent Pending in the U.S., Canada, and the European Union - CCK based oral appetite suppressant for the treatment of obesity, filed February 23, 2007
  
  

Professional Experience

• Appeared on Fox News in 2006, for inducing remission on a patient with metastatic lung cancer (to liver and spine) that was refractory to chemotherapy.
• Current cancer research includes being granted IND status as of Feb 24, 2007(investigational new drug) for use of angiotensin II to improve tumor blood flow during administration of cytotoxic cancer therapy.
• 2006- Present; Chief Science Officer and Director of research
  and Development; Vitalmax Vitamins
• 2003-Present; President and Medical Director
  The Institute for Healthy Aging, Delray Beach, FL
• 2003-2004; Chief Science Officer and Director of Research
  and Development, “Nutrophy”, Miami, FL
• 1999 - 2005; Assistant Director of
  Emergency Medicine, Bethesda Memorial Hospital,
  Boynton Beach, FL
• 1996-1999; Associate Director of Emergency Medicine and Director of Quality Improvement, Westside Regional
  Medical Center, Plantation, FL
• 1993-1996; Assistant Chief of Emergency Medicine; Consultant
  for Poisons and Overdoses; Director of Quality Improvement
  Walter Reed Army Medical Center, Washington, DC
• 1995-1996; Staff Emergency Physician, Shady Grove Adventist
  Hospital, Rockville, MD
• 1994-1996; Staff Emergency Physician, Sibley Memorial
  Hospital, Washington, DC
• 1993-1995; Staff Emergency Physician, Alexandria Hospital
  Alexandria, VA
• 1989-1990; Staff Emergency Physician, Fox Army Community
  Hospital, Redstone Arsenal, AL

Biographies
Mark A Rosenberg, MD
Breshan Nelson, Office Manager